JUSTIN ADRIEN: Open Payments
NPI 1770896532 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 5 payments from 5 companies in 2025. Trend: 2023 $1,100 · 2024 $642 · 2025 $159
Food & beverage: $93Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $66 |
| UCB, Inc. | 1 | $31 |
| Amgen Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: TREMFYA, Bimzelx, OTEZLA, NEMLUVIO, COSENTYX.
Industry payments across MD — which companies pay providers there.
